Authors: Curran, WJ Ajani, J Ang, K Bonanni, R Bruner, D Byhardt, R Eisenberg, B Gillin, MT Ginsberg, RJ Greven, K Grignon, D Hammond, E Layne, E McCormick, B Mehta, M Michalski, J Okunieff, P Sandler, H Scarantino, CW Willett, C

Citation: Wj. Curran et al., Radiation Therapy Oncology Group, research plan 2002-2006, INT J RAD O, 51(3), 2001, pp. V

Authors: Byhardt, R Scott, C

Citation: R. Byhardt et C. Scott, A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 Gy: Results of a randomized equivalence study: Regarding Nestle et al. IJROBP 2000;48 : 95-103, INT J RAD O, 50(3), 2001, pp. 837-837

Authors: Trotti, A Byhardt, R Stetz, J Gwede, C Corn, B Fu, K Gunderson, L McCormick, B Morris, M Rich, T Shipley, W Curran, W

Citation: A. Trotti et al., Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy, INT J RAD O, 47(1), 2000, pp. 13-47

Authors: Sause, W Kolesar, P Taylor, S Johnson, D Livingston, R Komaki, R Emami, B Curran, W Byhardt, R Dar, AR Turrisi, A

Citation: W. Sause et al., Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group, CHEST, 117(2), 2000, pp. 358-364

Authors: Movsas, B Scott, C Sause, W Byhardt, R Komaki, R Cox, J Johnson, D Lawton, C Dar, AR Wasserman, T Roach, M Lee, JS Andras, E

Citation: B. Movsas et al., The benefit of treatment intensification is age and histology-dependent inpatients with locally advanced nonsmall cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies, INT J RAD O, 45(5), 1999, pp. 1143-1149

Authors: Cooper, JS Guo, MD Herskovic, A Macdonald, JS Martenson, JA Al-Sarraf, M Byhardt, R Russell, AH Beitler, JJ Spencer, S Asbell, SO Graham, MV Leichman, LL

Citation: Js. Cooper et al., Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01), J AM MED A, 281(17), 1999, pp. 1623-1627